Repligen RGEN Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue (Gross) by Product | |||||
| Process Analytics Products | $81.24M+37.0% | $59.3M+4.4% | $56.82M+6.2% | $53.51M+11.4% | |
| Proteins Products | $97.44M+30.9% | $74.43M-28.1% | $103.46M-9.5% | $114.32M-7.6% | |
| Royalty | $296K+13.4% | $261K-31.9% | $383K+8.5% | $353K+64.2% | |
| Concentration Risk % by Geography | |||||
| Europe | 104%— | —— | 111%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Repligen break its business down?
- Repligen (RGEN) reports revenue (gross) by product across 3 parts — Process Analytics Products, Proteins Products and Royalty. Each is extracted from the segment footnotes and tracked over time.
- Where does Repligen's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Repligen's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
